Huiqiang Huang, Yan Gao, Xueping Li, Xuanye Zhang, Xiaoxiao Wang, Bing Bai, Ru Feng, Mingwei FU. "Sintilimab (anti-PD-1 antibody) combined with chidamide (an oral subtype-selective HDACi) followed by P-GemOx regimen in patients with treatment-naïve extranodal natural killer/T cell lymphoma (TN-ENKTL): A multicenter, open-label, single-arm, phase II study (SCENT-2 trial).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.7006